Immunosuppressive Agents: all 5,940 studies that test it
Page 40 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.
- Prospective, Multicentric, Phase II Randomized Controlled Trial on Two Parallel Groups Comparing the Efficacy of Two Immunosuppressive Drugs (methotrexate, Cyclophosphamide) in Large Granular Lymphocytes LeukemiaCompletedNCT01976182Phase 2
- Comparative Study of Rituximab Versus Combination of Rituximab and Intravenous Cyclophosphamide in Severe PemphigusStatus unknownNCT01974518Phase 3
- Efficacy Study Comparing Velcade Dexamethasone Thalidomide Versus Velcade Cyclophosphamide Dexamethasone as Induction Treatment in the Initial Management of Multiple Myeloma (IFM2013-04)CompletedNCT01971658Phase 3
- Induction Preoperative Chemotherapy for Patients With Locally Advanced Triple Negative Breast CancerCompletedNCT01969032Phase 2
- Everolimus in Selected Patients With Metastatic Melanoma: Efficacy and Safety StudyStatus unknownNCT01960829Phase 2
- Methotrexate in the Treatment of Chronic Idiopathic UrticariaCompletedNCT01960283Phase 3
- Drug-Drug Interaction Study Evaluating Effects of ASP015K on RosuvastatinCompletedNCT01959399Phase 1
- A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative ColitisCompletedNCT01959282Phase 2
- Study Comparing in Livertransplantation Recipients With Tacrolimus Alone Versus Tacrolimus&SirolimusCompletedNCT01958190Phase 4
- Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous NephropathyCompletedNCT01955187Phase 3
- A Study of Everolimus in the Treatment of Neurocognitive Problems in Tuberous SclerosisStatus unknownNCT01954693Phase 2
- iC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma and NeuroblastomaActive, not recruitingNCT01953900Phase 1
- Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2008Status unknownNCT01953770Not applicable
- Stereotactic Body Radiation Therapy and T-Cell Infusion in Treating Patients With Metastatic Kidney CancerTerminatedNCT01943188Phase 1
- Safety and Efficacy of Fingolimod in MS Patients in ChinaWithdrawnNCT01941004Phase 3
- Phase Ib/II Trials of RAD001 in Triple Negative Metastatic Breast CancerTerminatedNCT01939418Phase 1/2
- Thymoglobulin in Cadaver DonorCompletedNCT01939171Phase 2
- Pharmacokinetic Study of Thalidomide in Subjects With Multiple MyelomaCompletedNCT01937442Phase 1
- Etanercept and Celecoxib Alone/Combined Treatment in Effectiveness and Safety of Active Ankylosing SpondylitisCompletedNCT01934933Phase 4
- A Study Evaluating the Effectiveness of Tecfidera (Dimethyl Fumarate) on Multiple Sclerosis (MS) Disease Activity and Patient-Reported OutcomesCompletedNCT01930708Phase 4
- A Study to Assess the Relative Bioavailability Between Two ASP015K Tablets and the Food Effect of a New Tablet in Healthy Adult SubjectsCompletedNCT01929577Phase 1
- Evaluation of Early Use of Everolimus (EVE) on Cytomegalovirus (CMV) Infection in Renal Transplant RecipientsStatus unknownNCT01927588Phase 4
- BG00012 Regional Absorption StudyCompletedNCT01924832Phase 1
- Adjuvant Therapy With Thalidomide After Curative Resection of Hepatocellular CarcinomaStatus unknownNCT01924624Not applicable
- A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic LeukemiaActive, not recruitingNCT01920737Phase 2
- A Phase II Trial of Adjuvant Radiotherapy Combined With Chemotherapy for Patients With High-risk Endometrial CancerCompletedNCT01918124Phase 2
- Bone Marrow Transplant With Abatacept for Non-Malignant DiseasesCompletedNCT01917708Phase 1
- A Clinical Trial to Evaluate the Efficacy of Abatacept in Moderate to Severe Alopecia AreataWithdrawnNCT01917058Phase 2
- Phase II Pilot Study Assessing Efficacy of a Cisplatin - Metronomic Cyclophosphamide Treatment in Patients With Metastatic Triple Negative Breast Cancer Resistant to Anthracyclines and TaxanesTerminatedNCT01910870Phase 2
- Phase II Pilot Study Assessing Efficacy of a Cisplatin - Métronomic Cyclophosphamide Treatment in Patients With Stade IV Triple Negative Breast Cancer Secondary Resistant to Anthracyclines and TaxanesTerminatedNCT01910844Phase 2
- Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung CancerCompletedNCT01909752Phase 2
- Islet Cell Transplant for Type 1 DiabetesActive, not recruitingNCT01909245Phase 2
- A Trail of Neoadjuvant Endostar in Combination With Chemotherapy in Breast CancerStatus unknownNCT01907529Phase 2/3
- Study on Two Different Formulations of 6-mercaptopurine. Tablet Versus Oral LiquidStatus unknownNCT01906671Phase 4
- A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative ColitisCompletedNCT01900574Phase 1
- Effect of the Combination of Methotrexate and Adalimumab on Reduction of Immunization in Ankylosing Spondylitis (COMARIS)CompletedNCT01895764Phase 4
- Safety and Pharmacokinetic Characteristics of HD203 Liquid in Healthy Male VolunteersCompletedNCT01894412Phase 1
- A Study to Estimate the Relative Bioavailability, Tolerability and Safety of a Single Dose of Belimumab Self-Administered Subcutaneously (SC) by Healthy SubjectsCompletedNCT01894360Phase 1
- Thalidomide in the Treatment of Chronic Plaque Psoriasis.CompletedNCT01891019Phase 2
- Cardiac Allograft Remodeling and Effects of SirolimusTerminatedNCT01889992Phase 1
- Pharmacokinetic Studies of Tacrolimus in Transplant PatientsCompletedNCT01889758Phase 4
- Sirolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients At High Risk for Cholangiocarcinoma Recurrence After Liver Transplant or SurgeryCompletedNCT01888302Phase 1
- Assessing Everolimus in Fist Line Treatment on Patients With Metastatic Kidney CancerTerminatedNCT01888042Phase 2
- Myocet + Cyclophosphamide + Metformin Vs Myocet + Cyclophosphamide in 1st Line Treatment of HER2 Neg. Metastatic Breast Cancer PatientsCompletedNCT01885013Phase 2
- A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of MethotrexateCompletedNCT01884636Phase 1
- Tumor-Infiltrating Lymphocytes And Low-Dose Interleukin-2 Therapy Following Cyclophosphamide And Fludarabine In Patients With MelanomaCompletedNCT01883323Phase 2
- ATG in Haploidentical HSCT for Acute Graft-versus-host Disease ProphylaxisCompletedNCT01883180Phase 4
- A Study to Evaluate the Effect of Advagraf Conversion From Prograf in Liver Transplant SubjectsCompletedNCT01882322Phase 4
- Exploring the Activity of RAD001 in Vestibular Schwannomas and MeningiomasCompletedNCT01880749Early Phase 1
- A Study of The Effect of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate on Articular Damage in The Hand in Patients With Moderate to Severe Rheumatoid Arthritis Who Have an Inadequate Response to Non-Biological DMARDsWithdrawnNCT01878318Phase 4
- Effectiveness Of Expectant Management In The Tubal Ectopic PregnancyCompletedNCT01876004Phase 4
- Comparison of NODAT in Kidney Transplant Patients Receiving Belatacept Versus Standard ImmunosuppressionStatus unknownNCT01875224Phase 4
- Long-Term Efficacy and Safety of CT-P10 in Patients With RACompletedNCT01873443Phase 1
- Evaluation of Patient Performance Using the Metoject Device for Subcutaneous Injection in Rheumatoid Arthritis (RA)PatientCompletedNCT01871961Phase 1
- Initial Treatment With Golimumab in Early PsACompletedNCT01871649Phase 3
- Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)CompletedNCT01868269Phase 3
- Safety and Efficacy Study of Etanercept for Aneurysmal Subarachnoid HemorrhageWithdrawnNCT01865630Phase 1
- Prediction of Response to Certolizumab Pegol Treatment by Functional MRI of the BrainCompletedNCT01864265Phase 3
- Phase 1 TheraSphere + Everolimus With Neuroendocrine Tumors (NETs) + Liver Only or Liver Dominant DiseaseWithdrawnNCT01864070Phase 1
- Effect of Teriflunomide on Immune Cell Subsets in the Blood of Patients With Multiple SclerosisCompletedNCT01863888Phase 3
- Low-dose VS High-dose IV Cyclophosphamide for Proliferative LN in ChildrenTerminatedNCT01861561Phase 4
- BHCG Level in Day 4,7, in Comparison to Day 10 as an Indicator for Treatment SuccessStatus unknownNCT01860690Phase 4
- Study of Weekly Carfilzomib, Cyclophosphamide and Dexamethasone In Newly Diagnosed Multiple Myeloma Patients (wCCyd)CompletedNCT01857115Phase 1/2
- Anti-thymocyte Globulins for Graft-versus-host Disease ProphylaxisCompletedNCT01856803Phase 4
- Tuberous Sclerosis Complex: Facial Angiofibroma Skin CreamCompletedNCT01853423Phase 1
- Treatment of Dry Eye Using 0.03% Tacrolimus Eye DropsCompletedNCT01850979Phase 4
- Introducing a Single IV Abatacept Treatment in RA Patients Currently Receiving Weekly SC Abatacept to Simulate a HolidayCompletedNCT01846975Phase 4
- Randomised Study Comparing Different Dosages of Rabbit ATG in Patients With SAAStatus unknownNCT01844635Phase 3
- Therapeutic Efficacy of Topical Sirolimus in Early Stage Cutaneous T-cell Lymphoma (CTCL)WithdrawnNCT01843998Phase 2
- Vaccine Therapy and Basiliximab in Treating Patients With Acute Myeloid Leukemia in Complete RemissionCompletedNCT01842139Phase 1
- Maintenance Treatment of Non Segmental Vitiligo With Tacrolimus Ointment 0.1% Versus ControlTerminatedNCT01841008Phase 2/3
- A Study to Assess the Safety and Efficacy of ADVAGRAF (Tacrolimus Modified Release Formulation) in Kidney Transplant Patients Who Were Treated With PROGRAFCompletedNCT01839929Phase 4
- Phase 1 Dose Finding Study of Belinostat for Treatment of Patients With Peripheral T-cell Lymphoma (PTCL)CompletedNCT01839097Phase 1
- An Efficacy and Safety Study of BG00012 (Dimethyl Fumarate) in Asian Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)CompletedNCT01838668Phase 3
- Early Conversion From CNI to Belatacept in Renal Transplant Recipients With Delayed and Slow Graft FunctionStatus unknownNCT01837043Phase 2
- High-dose Cyclophosphamide for Severe Refractory Crohn DiseaseWithdrawnNCT01836289Phase 1/2
- Low-dose Cyclophosphamide and Outpatient IV Interleukin-2 in Metastatic MelanomaWithdrawnNCT01833767Phase 2
- RAD001 in Advanced SarcomaCompletedNCT01830153Phase 2
- An Efficacy and Safety Study of Tacrolimus Ointment in Adult Participants With Atopic DermatitisCompletedNCT01828879Phase 4
- Neoadjuvant Rapamycin in Patients Undergoing Radical CystectomyCompletedNCT01827618Early Phase 1
- The Efficacy of Enteral Nutrition in Fill of the Treatment Blank Period of the Postoperative Maintain Remission Medication for Crohn's Disease (CD)Status unknownNCT01823042Not applicable
- 3rd Generation GD-2 Chimeric Antigen Receptor and iCaspase Suicide Safety Switch, Neuroblastoma, GRAINActive, not recruitingNCT01822652Phase 1
- Sirolimus, Idarubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaCompletedNCT01822015Early Phase 1
- Cimzia Versus Cimzia Plus Azathioprine in the Treatment of Active Crohn's DiseaseStatus unknownNCT01817972Phase 3
- Impact on T Cell Immune Activation and Inflammation of Triptolide Woldifii in HIV-infected Immunological Non-respondersStatus unknownNCT01817283Phase 1/2
- Efficacy Study on Dimethyl Fumarate to Treat Moderate to Severe Plaque PsoriasisWithdrawnNCT01815723Phase 3
- Sirolimus for Eosinophil-Associated Gastrointestinal DisordersTerminatedNCT01814059Phase 1
- Efficacy and Safety of the Mammalian Target of Rapamycin (mTor Rapamycin) Inhibitor in Vascular MalformationsCompletedNCT01811667Phase 3
- A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Sirolimus in Healthy SubjectsCompletedNCT01809860Phase 1
- Myfortic in High MELD Liver TransplantationWithdrawnNCT01807767Not applicable
- Safety Study of Adding Everolimus to Adjuvant Hormone Therapy in Women With High Risk of Relapse, ER+ and HER2- Primary Breast Cancer, Free of Disease After Receiving at Least One Year of Adjuvant Hormone TherapyActive, not recruitingNCT01805271Phase 3
- Phase II Open Label, Non-randomized Study of Sorafenib and Everolimus in Relapsed and Non-resectable OsteosarcomaCompletedNCT01804374Phase 2
- Comparison of 2 Immunomodulator Withdrawal Schemes for Infliximab Monotherapy in Active Pediatric Crohn's Disease After Thiopurine FailureTerminatedNCT01802593Phase 4
- The Efficacy of RAD 001 as Second Line Therapy in Patients With Transitional Cell Carcinoma TCC of the UrotheliumCompletedNCT01801137Phase 2
- Cataract Surgery With Intracameral Triamcinolone in InfantsCompletedNCT01800708Not applicable
- Prograf-Advagraf Cross Over Conversion StudyCompletedNCT01797341Phase 3
- Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-based Immunosuppressive ProtocolTerminatedNCT01797315Phase 4
- NY-ESO-1 T Cells in OG CancerTerminatedNCT01795976Phase 2
- Stopping TNF Alpha Inhibitors in Rheumatoid ArthritisActive, not recruitingNCT01793519Phase 4
- Study of FTY720 in Patients With UveitisWithdrawnNCT01791192Phase 2